All Stories

  1. Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives

    Article • Patient Related Outcome Measures, December 2019, Taylor & Francis

    Dejan Jakimovski, Osman OZEL